Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives
Author:
Funder
Queensland University of Technology
Publisher
Elsevier BV
Reference192 articles.
1. State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?;Chmiel;Respir. Res.,2003
2. Inhaled ciprofloxacin-loaded poly(2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections;Sabuj;PLoS One,2021
3. Pharmacokinetic-Pharmacodynamic target attainment analyses to determine optimal dosing of ceftazidime-avibactam for the treatment of acute pulmonary exacerbations in patients with cystic fibrosis;Bensman;Antimicrob. Agents Chemother.,2017
4. Inhalation drug delivery in combating pulmonary infections: advances and challenges;Kumbhar;J. Drug Deliv. Sci. Technol.,2023
5. Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies;Jennings;Cell Rep.,2021
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ciprofloxacin-Loaded Inhalable Formulations against Lower Respiratory Tract Infections: Challenges, Recent Advances, and Future Perspectives;Pharmaceutics;2024-05-11
2. Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives;International Journal of Pharmaceutics;2024-04
3. Application of Nanobiomedicine in Acute Lung Injury;Journal of Biomaterials and Tissue Engineering;2024-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3